According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...

According to a new report from Intel Market Research, the global Digital Therapeutics Devices market was valued at USD 6.51 billion in 2025 and is projected to grow from USD 7.82 billion in 2026 to USD 35.78 billion by 2034, exhibiting a robust CAGR of 21.0% during the forecast period (2026–2034). This rapid expansion is underpinned by escalating prevalence of chronic illnesses, soaring...

The United States represents a significant market for deferasirox, driven by the growing prevalence of transfusion-dependent blood disorders such as thalassemia, sickle cell disease, and myelodysplastic syndromes. The country benefits from a well-established healthcare infrastructure, advanced diagnostic capabilities, and strong access to specialized hematology treatments. Increasing awareness...

The United States represents a major contributor to the smart drug delivery system market, driven by advanced healthcare infrastructure, high adoption of connected medical devices, and the growing prevalence of chronic diseases such as diabetes and cardiovascular disorders. Increasing investments in digital health technologies and strong focus on patient-centered care continue to support the...